Cancer Assistance Program

Tune into the most recent episode of the : Radioligand Therapy for Prostate Cancer: The New Kid on the Block

A promising new treatment is changing the landscape for advanced prostate cancer. In this episode, Dr. Bill Evans is joined by Dr. Ali Khan Lalani, Associate professor, McMaster University GU disease site team chair, Juravinski Cancer Centre, and Anne Khoorshed, Radiation Safety Officer, Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, to explore radioligand therapy (Pluvicto), an innovative targeted treatment now available in Hamilton.

They break down how this “smart bomb” approach works, who may be eligible, what patients can expect, and why this advancement is bringing new hope to men with advanced prostate cancer. From improved quality of life to exciting future research, this conversation offers an accessible look at one of cancer care’s most promising emerging therapies.

Available now at https://loom.ly/DrvOhI4 or find it on Apple, Spotify and Youtube.

Tune into the most recent episode of the : Radioligand Therapy for Prostate Cancer: The New Kid on the Block

A promising new treatment is changing the landscape for advanced prostate cancer. In this episode, Dr. Bill Evans is joined by Dr. Ali Khan Lalani, Associate professor, McMaster University GU disease site team chair, Juravinski Cancer Centre, and Anne Khoorshed, Radiation Safety Officer, Hamilton Health Sciences and St. Joseph’s Healthcare Hamilton, to explore radioligand therapy (Pluvicto), an innovative targeted treatment now available in Hamilton.

They break down how this “smart bomb” approach works, who may be eligible, what patients can expect, and why this advancement is bringing new hope to men with advanced prostate cancer. From improved quality of life to exciting future research, this conversation offers an accessible look at one of cancer care’s most promising emerging therapies.

Available now at https://loom.ly/DrvOhI4 or find it on Apple, Spotify and Youtube.